论文信息 - Liposomal irinotecan (nal-IRI) plus 5-fluorouracil/levoleucovorin (5 FU/LV) vs 5-FU/LV in Japanese patients (pts) with gemcitabine-refractory metastatic pancreatic cancer (mPAC) - 字舞流文

Liposomal irinotecan (nal-IRI) plus 5-fluorouracil/levoleucovorin (5 FU/LV) vs 5-FU/LV in Japanese patients (pts) with gemcitabine-refractory metastatic pancreatic cancer (mPAC)

J. Furuse | M. Ikeda | K. Sugimori | T. Okusaka | S. Nakamori | T. Ioka | M. Kanai | M. Ueno | R. Tang | M. Ozaka | A. Sato | S. Shimizu | Y. Komatsu | M. Furukawa | K. Kawabe | P. Chugh